Table:
begin	end	state
1	15	non-cytoplasmic
16	34	transmembrane
35	79	cytoplasmic
80	100	transmembrane
101	119	non-cytoplasmic
120	141	transmembrane
142	157	cytoplasmic
158	177	transmembrane
178	189	non-cytoplasmic
190	205	transmembrane
206	207	non-cytoplasmic
208	216	cytoplasmic
217	235	transmembrane
236	662	non-cytoplasmic

Input:
>WP_012501363.1 NCBI__GCF_000020505.1:WP_012501363.1
MEATREIYWNIDHGTVALMYLMALAAVAVMVYGFRERIALWQKGKSLDRFDHLQQRLAHF
ITDALSQRKVLNVMQGGLPHALLFWGFLLLFIGTVLVMLQADLLAPLFSVNLLSGDFYRL
YSFVLDLAGLAAMLALAALAVRRFIIKPAGLETSSADVAIHLLLFAILFSGFLIEGARMA
VTEVRDNPALAAWSPVGAVFARPFLGMDEHLVRGAHKGFWLLHLLFGLGFLAVIPRTKLR
HLATTSGGSLLEPHEPTGTYSAIDLEDEHIEQFGASVVSDLSWKDLFDTDACMQCGRCQQ
RCPAHLTGKPLSPMKVITDIGELAGNENGKGLVEKVSRDALWSCTTCRACEQICPASIEH
IGKIIEMRRSLALMEGEFPGDEARRACEAIEVNGNPFGLSATSRGDWAKGLPVSIIKGKC
DADILYFTGCYASHDPRNRKVAESFVRICEAAGVTVAILGGAERCCGEPARKLGNEYLYR
MVADSNIEAIRASGARRIVTACPHCFNTLARDYRELGLDLPVEHHSTFIARLINDGKLKL
KPERFTATFHDSCYLARYQEIAEEPREVVRAAGIKLVEMAAFGKNGFCCGAGGGRILAEE
KLGTPIVDERLRQARQTGAKSLVSACPFCLSMFEDGLKRADSREPIKAYDLAEIVARSID
RK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server